CJC-1295 Peptide Therapy

FAQ

Click on a question to see more

• What is the difference between CJC-1295 and Sermorelin?

  Both stimulate natural GH release, but CJC-1295 has a significantly longer half-life (days vs. minutes for Sermorelin), allowing for less frequent dosing. Some protocols combine both for comprehensive GH optimization.

• Why combine CJC-1295 with Ipamorelin?

  Ipamorelin provides an initial "spark" of GH release while CJC-1295 extends and sustains that elevation. Together they mimic your body's natural growth hormone patterns more effectively than either alone, without increasing cortisol or prolactin.

• How quickly will I see results?

  Improved energy and sleep quality are often noticed within 2-3 weeks. Body composition changes (muscle tone, fat reduction) typically become apparent at 4-6 weeks with consistent use.

• Is CJC-1295 FDA-approved?

  No. CJC-1295 is not FDA-approved and is used off-label. Clinical research in healthy adults has demonstrated its safety and efficacy for sustained GH elevation when properly monitored.

• What are the side effects?

  Generally well-tolerated. Some may experience injection site reactions, mild water retention, or temporary flu-like symptoms as the body adjusts. These typically resolve within the first week.